"Our physicians, nurse practitioners and staff are committed to providing the best in the modern science and art of neurology to all those who seek our services including our patients, their families, our students, colleagues and community organizations."

During the past decade, Guilford Neurologic Associates conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 15 clinical trials were completed, i.e. on average, 107.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guilford Neurologic Associates" #1 sponsor was "Allergan" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guilford Neurologic Associates" #1 collaborator was "Medical University of South Carolina" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "FusionHealth LLC" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Neurological Emergencies Treatment Trials Network (NETT)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Guilford Neurologic Associates" are "Stroke" (4 trials), "Alzheimer's Disease" (3 trials), "Ischemic Stroke" (3 trials), "Cervical Dystonia" (2 trials) and "Epilepsies, Partial" (2 trials). Many other conditions were trialed in "Guilford Neurologic Associates" in a lesser frequency.

Most popular intervention types in "Guilford Neurologic Associates" are "Drug" (19 trials), "Other" (4 trials), "Device" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Botulinum toxin type A" (2 trials), "Cladribine Tablets" (2 trials), "Crenezumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Guilford Neurologic Associates" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Guilford Neurologic Associates". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Guilford Neurologic Associates, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Guilford Neurologic Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".